Haemodialysis (HD) is the commonest form of kidney replacement therapy in the world,
accounting for approximately 69% of all kidney replacement therapy and 89% of all dialysis …

Background: The global epidemiology of end-stage kidney disease (ESKD) reflects each
nation's unique genetic, environmental, lifestyle, and sociodemographic characteristics. The …

Abstract The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative
(KDOQI) has provided evidence-based guidelines for hemodialysis vascular access since …

BACKGROUND Vascular replacement and repair for the treatment of atherosclerotic
disease, infection, and traumatic injury are some of the most commonly performed surgical …

Cardiovascular defects, injuries, and degenerative diseases often require surgical
intervention and the use of implantable replacement material and conduits. Traditional …

Importance National initiatives have emphasized the use of autogenous arteriovenous
fistulas (AVFs) for hemodialysis, but their purported benefits have been questioned …

Rationale & Objective Peritoneal dialysis (PD)-related peritonitis carries high morbidity for
PD patients. Understanding the characteristics and risk factors for peritonitis can guide …

Objective To determine the global capacity (availability, accessibility, quality, and
affordability) to deliver kidney replacement therapy (dialysis and transplantation) and …

Advances in standards of care have extended the life expectancy of patients with kidney
failure. However, options for chronic vascular access for haemodialysis—an essential part of …

This commentary critically examines key assumptions and recommendations in the 2006
Kidney Disease Outcomes Quality Initiative vascular access guidelines, and argues that …